» Articles » PMID: 11711530

Modulation of Apolipoprotein D and Apolipoprotein E MRNA Expression by Growth Arrest and Identification of Key Elements in the Promoter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Nov 17
PMID 11711530
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Apolipoprotein D (apoD) and apolipoprotein E (apoE) are co-expressed in many tissues, and, in certain neuropathological situations, their expression appears to be under coordinate regulation. We have previously shown that apoD gene expression in cultured human fibroblasts is up-regulated when the cells undergo growth arrest. Here, we demonstrate that, starting around day 2 of growth arrest, both apoD and apoE mRNA levels increase between 1.5- and 27-fold in other cell types, including mouse primary fibroblasts and fibroblast-like and human astrocytoma cell lines. To understand the regulatory mechanisms of apoD expression, we have used apoD promoter-luciferase reporter constructs to compare gene expression in growing cells and in cells that have undergone growth arrest. Analysis of gene expression in cells transfected with constructs with deletions and mutations in the apoD promoter and constructs with artificial promoters demonstrated that the region between nucleotides -174 and -4 is fully responsible for the basal gene expression, whereas the region from -558 to -179 is implicated in the induction of apoD expression following growth arrest. Within this region, an alternating purine-pyrimidine stretch and a pair of serum-responsive elements (SRE) were found to be major determinants of growth arrest-induced apoD gene expression. Evidence is also presented that SREs in the apoE promoter may contribute to the up-regulation of apoE gene expression following growth arrest.

Citing Articles

Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study.

Wang Z, Chen H, Sun L, Wang X, Xu Y, Tian S Comput Struct Biotechnol J. 2024; 23:1051-1064.

PMID: 38455068 PMC: 10918487. DOI: 10.1016/j.csbj.2024.02.015.


Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders.

Del Valle E, Rubio-Sardon N, Menendez-Perez C, Martinez-Pinilla E, Navarro A Int J Mol Sci. 2023; 24(21).

PMID: 37958618 PMC: 10650001. DOI: 10.3390/ijms242115631.


Apolipoprotein D in Oxidative Stress and Inflammation.

Fyfe-Desmarais G, Desmarais F, Rassart E, Mounier C Antioxidants (Basel). 2023; 12(5).

PMID: 37237893 PMC: 10215970. DOI: 10.3390/antiox12051027.


Single-cell analysis of menstrual endometrial tissues defines phenotypes associated with endometriosis.

Shih A, Adelson R, Vashistha H, Khalili H, Nayyar A, Puran R BMC Med. 2022; 20(1):315.

PMID: 36104692 PMC: 9476391. DOI: 10.1186/s12916-022-02500-3.


The Lipocalin Apolipoprotein D Functional Portrait: A Systematic Review.

Sanchez D, Ganfornina M Front Physiol. 2021; 12:738991.

PMID: 34690812 PMC: 8530192. DOI: 10.3389/fphys.2021.738991.